At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Title Type Shares Traded Sorted Ascending Price Range
Jan 31, 2008 topper james n Director Buy 8,800 10.21 - 10.50
Jul 11, 2008 bloch stephen m Director Automatic Sell 8,893 12.55
Jul 28, 2008 bloch stephen m Director Automatic Sell 9,000 15.23
Mar 4, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 9,000 9.85 - 10.12
Mar 4, 2008 topper james n Director Buy 9,000 9.85 - 10.12
Feb 12, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 9,400 9.99 - 10.12
Feb 12, 2008 topper james n Director Buy 9,400 9.99 - 10.12
Jan 2, 2008 crowley john f Officer Automatic Sell 9,600 10.13 - 10.67
Feb 19, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 9,600 9.74 - 10.12
Feb 19, 2008 topper james n Director Buy 9,600 9.74 - 10.12
Feb 25, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 9,700 9.45 - 9.95
Feb 25, 2008 topper james n Director Buy 9,700 9.45 - 9.95
Jul 31, 2008 bloch stephen m Director Automatic Sell 10,000 15.47 - 15465.00
Feb 29, 2008 crowley john f Officer Option Execute 10,000 0.64
Dec 13, 2007 crowley john f Officer Option Execute 10,000 0.64
Feb 1, 2008 crowley john f Officer Automatic Sell 10,000 10.00
Nov 3, 2008 crowley john f Officer Automatic Sell 10,000 10.27 - 10.29
Aug 12, 2009 crowley john f Officer Disposition (Non Open Market) 10,000 n/a
Jun 17, 2011 crowley john f Officer Disposition (Non Open Market) 10,000 n/a
Aug 11, 2011 crowley john f Officer Buy 10,000 4.20
Showing 261-280 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy